Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0671
-0.0079 (-10.53%)
At close: May 27, 2026
Iterum Therapeutics Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Iterum Therapeutics in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Iterum Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Aug '25 | Oct '25 | Nov '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 30, 2026 |
| Maxim Group | Maxim Group | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 4, 2026 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.